The Trilucent™ breast implant experience

Clinical Risk

Volumn 9, Issue 1, 2003, Pages 1-9

  Kirkpatrick, Niall ^a   Jones, Barry ^a,b  

^a WELLINGTON HOSPITAL   (United Kingdom)

^b NONE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

SILICONE;

ARTICLE; BREAST AUGMENTATION; BREAST ENDOPROSTHESIS; DEVICE; HEALTH HAZARD; HUMAN; PLASTIC SURGERY; RISK ASSESSMENT; SAFETY;

EID: 0037246622     PISSN: 13562622     EISSN: None     Source Type: Journal    
DOI: 10.1258/135626203762301832     Document Type: Article

References (33)

1. Gumucio CA, Pin P, Young VL, Destouet J, Monsees B, Eichling J. The effect of breast implants on the radiographic detection of microcalcification and soft-tissue masses. Plast Reconstr Surg 1989; 84: 772-782
2. Young VL, Diehl GJ, Eichling J, Monsees BS, Destouet J. The relative radiolucencies of breast implant filler materials. Plast Reconstr Surg 1993; 91: 1066-1072
3. Tinlder JJB, Campbell HJ, Senior JM, Ludgate SM. Evidence for an association between the implantation of silicones and connective tissue disease. Medical Devices Directorate Report MDD/92/42, February 1993. Copies available from http://www.medical-devices.gov.uk
4. Gott DM, Tinkler JJB. Evaluation of evidence for an association between the implantation of silicones and connective tissue disease. Medical Devices Agency Report, December 1994. Copies available from http://www.medical-devices.gov.uk
5. Independent Review Group (IRG). Silicone Gel Breast Implants - The report of the Independent Review Group, July 1998. Copies available from http://www.silicone-review.gov.uk/silicone_implants.pdf
6. Young VL, Lund H, Destouet J, Pidgeon L, Ueda K. Biocompatibility of radiolucent breast implants. Plast Reconstr Surg 1991; 88: 462-465
7. Young VL, Lund H, Ueda K, Pidgeon L, Schorr MW, Kreeger J. Bleed of and biologic response to triglyceride filler used in radiolucent breast implants. Plast Reconstr Surg 1996; 97: 1179-1195
8. Barnett MP. Triglyceride-filled breast implants. Plast Reconstr Surg 1997; 99: 2105-2106
9. Young VL. Triglyceride-fiUed breast implants: Reply. Plast Reconstr Surg 1997; 99: 2106-2107
10. Brucker R., Winger EE, Sendelbach L. Bleed of and biologic response to triglyceride filler used in radiolucent breast implants. Plast Reconstr Surg 1997; 99: 2107-2108
11. Young VL. Bleed of and biologic response to triglyceride filler used in radiolucent breast implants: Reply. Plast Reconstr Surg 1997; 99: 2108-2109
12. Davies DM and Kirkpatrick WN. Lipid emulsification after implant rupture. Br J Plast Surg 1999; 52: 238
13. Austin A. Adverse incident reporting to the Medical Devices Agency - A review of reports involving Trilucent breast implants. Br J Plast Surg 2000; 53: 313-316
14. Monstrey S, Delanghe J, Christophe A, Dhooge W, de Greyt W, Bernard D, van Landuyt K, Blondeel P. Biocompatibility and oxidative stability of radiolucent breast implants. Plast Reconstr Surg 2000; 105: 1429-1434
15. Opitz PG, Young VL. Experience with soybean oil-fifled breast implants in a Swedish surgical practice. Aesth Surg J 1998; 18: 183-196
16. AN1999(01) - Trilucent™ breast implants: voluntary withdrawal. Medical Devices Agency Advisory Notice, March 1999. Copies can be obtained from: MDA Business Services, Hannibal House, Elephant and Castle, London SE1 6TQ, UK
17. Statement on the safety of Trilucent breast implants. Medical Devices Agency, May 2000. Copies can be obtained from: MDA Business Services, Hannibal House, Elephant and Castle, London SE1 6TQ, UK
18. HN2000(05) - Trilucent™ breast implants: recommendation to remove. Medical Devices Agency Hazard Notice, June 2000. Copies can be obtained from: MDA Business Services, Hannibal House, Elephant and Castle, London SE1 6TQ, UK
19. Armstrong AP, Jones BM. Patient satisfaction with Trilucent™ breast implants. Br J Plast Surg 2000; 53: 479-483
20. McGregor JC. Further comment on Trilucent breast implants. Br J Plast Surg 2001; 54: 466-467
21. 1H) NMR analysis of lipid oxidation products in explant soyabean oil specimens. Trilucent® information: http://www.trilucentinfo.com
22. Kirkpatrick WNA, Jones BM. The history of Trilucent implants and a chemical analysis of the triglyceride filler in 51 consecutively removed Trilucent breast prostheses. Br J Plast Surg 2002; 55(6): 479-489
23. Dolezel B, Adamirova L, Vondracek P, Naprstek Z. In vivo degradation of polymers. II. Change of mechanical properties and cross-link density in silicone rubber pacemaker lead insulations during long-term implantation in the human body. Biomaterials 1989; 10: 387-392
24. Choudhary S, Cadier MAM. Do the oil-based breast implants bleed a lot? Plast Reconstr Surg 1999; 104: 1940
25. Rizkalla M, Duncan C, Mathews RN. Trilucent breast implants: a 3-year series. Br J Plast Surg 2001; 54: 125-127
26. Choudhary S, Cadier MAM, Cottrell BJ. Local tissue reactions to oil-based breast implant bleed. Br J Plast Surg 2000; 53: 317-318
27. Papanastasiou S, Odili J, Newman P, Evans J. Are triglyceride breast implants really biocompatible? With invited discussion by Young VL. Ann Plast Surg 2000; 45: 172-176
28. McArthur PA, Green AR, Hancock K. Histological examination of the capsules surrounding Trilucent breast implants. Br J Plast Surg 2001; 54: 684-686
29. 1H) NMR aanalysis of lipid peroxidation products in soybean oil samples from explanted and retained breast implants. Report prepared for AEI Inc, 2000. Trilucent® information: http://www.trilucentinfo.com
30. Williams GM. Assessment of cancer risk associated with exposure to soybean oil filler compounds and peroxidation products potentially released from Trilucent breast implants. Report prepared for AE1 Inc, 2000. Trilucent® information: http://www.trilucentinfo.com
31. Sullivan R. Direct-to-consumer advertising: the future in Europe. J R Soc Med 2000; 93: 400-401
32. Balen P. Breast implants. Clinical Risk 2002; 8(5): 177-184
33. Davies E, Evans G. 3M Capital Hip Replacements: the Isle of Wight experience. Clinical Risk 1999; 5: 115-119